Archive for the ‘Health Policy’ Category

Obesity Care Is Emerging as an Effective Tool for Prevention

June 15, 2024 — For decades now, thinking about obesity that pits treatment against prevention has hampered efforts to “tackle” obesity. At the Boston Course in Obesity Medicine yesterday, ConscienHealth founder Ted Kyle examined this either/or thinking and suggested it is a mistake. In fact, it is becoming apparent that obesity care is a critical tool for prevention of […]

Evolving Obesity Care: How Do We Get There from Here?

June 14, 2024 — It is unmistakable, Lee Kaplan tells us. Obesity care is evolving. But the change is painfully slow and inadequate – especially in comparison to the rapid advancement in tools for treating obesity. The slow progress is especially painful when you compare it to the progress made against HIV or COVID. In 1984, HIV was almost […]

Distinguishing Wishes and Beliefs from Facts in Evidence

June 13, 2024 — In the prevention of childhood and adolescent obesity, let us have our wishes and beliefs, but distinguish them from facts in evidence. Wishes are good things. They are the muses which impel us to action to work for a better future. Belief is a good thing. Our staunch belief that something can work gives us […]

Can Novo Nordisk Dodge a Senate Subpoena on Pricing?

June 12, 2024 — Senator Bernie Sanders doesn’t want to let this go. Novo Nordisk isn’t eager to cut its thousand-dollar list price for Ozempic. Nor is it eager to face a grilling about this in the Senate. So yesterday, Sanders announced that the Senate Health, Education, Labor, and Pensions committee will vote next Tuesday on a subpoena for […]

Marginalizing People with the Greatest Need for Obesity Care

June 3, 2024 — The STOP Obesity Alliance released new data Friday from an exhaustive analysis of access to obesity medicines in Medicaid programs across the United States. It’s not a pretty picture. It gives us more data to show how we are marginalizing people with the greatest need for obesity care. No state fully covered all forms of […]

What Happens When Prevention Outcomes Contradict Beliefs?

June 2, 2024 — The Obesity and Energetics Offerings from the Indiana University School of Public Health and the University of Alabama at Birmingham NORC certainly got our attention this week with an entry titled “Cherished Hypotheses Meet Hard Facts.” That entry links us to two new systematic reviews of randomized controlled trials to assess prevention of obesity in […]

Compounded Obesity Medicines Signal Distress

June 1, 2024 — This is a problem of human mistakes. Compounding pharmacies are exploiting the failure of pharmaceutical companies to meet the scale of need for effective obesity medicines. So people with a serious medical need for these medicines face a hideous choice. Suffer without them or take a chance on dodgy compounded products. The fact that this […]

Prediction: Guidelines Will Disappoint Ultra-Processed Hardliners

May 31, 2024 — It’s difficult to make predictions – especially about the future. Nonetheless, it’s not hard to see that the new 2025 edition of dietary guidelines will disappoint ultra-processed hardliners. The rhetoric from that sector sounds increasingly like something from a highly polarized presidential campaign. We pity the nutrition scientists and clinicians who have the hard job […]

Can’t, Won’t, Don’t: Why People Stop Taking Obesity Medicines

May 30, 2024 — In a world that systematically denies people access to obesity medicines, the rush of reports that people frequently stop taking them makes us wonder. How does this qualify as news? Why do reporters repeatedly paint a misleading picture of non-compliant patients? Yet, health reporters keep offering up this narrative. The latest prompt for this is […]

FDA Faces Questions About Drug Safety for People with Obesity

May 24, 2024 — At a hearing this week fo the U.S. House Committee on Energy and Commerce, Representative Robin Kelly asked the Director of the FDA Center for Drug Evaluation and Research, Patrizia Cavazzoni, what the agency is doing to ensure that drug labeling adequately protects the safety of people with obesity: “Patients with obesity are frequently excluded […]